Usa News

Alzheimer’s disease drug slows cognitive decline in landmark study



Biogen and Eisai have reported results from a large, late-stage clinical trial of lecanemab, a drug they are developing.

nytimes Gt

Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.
Back to top button